Towards a polymeric binding mimic for cytochrome CYP2D6.

A series of fluorescent molecularly imprinted polymers has been prepared with a view to generating material capable of mimicking the binding characteristics of the metabolically important cytochrome isoform CYP2D6. Such polymers would have the possibility to form the sensing element in a high-throughput assay for the prediction of CYP2D6 affinity. The imprinted polymers possessed binding-dependent fluorescence. They re-bound their templates and various cross-reactivities were encountered for test compound/drug recognition. One polymer in particular exhibited a rational discrimination amongst the related synthetic templates and was reasonably successful in recognising CYP2D6 substrates from a drug panel.

[1]  A. Turner,et al.  "Bite-and-Switch" approach using computationally designed molecularly imprinted polymers for sensing of creatinine. , 2001, Biosensors & bioelectronics.

[2]  J. Stewart.  Optimization of parameters for semiempirical methods I. Method , 1989 .

[3]  W. Powell,et al.  Fluorescent Functional Recognition Sites through Molecular Imprinting. A Polymer-Based Fluorescent Chemosensor for Aqueous cAMP. , 1998, Analytical chemistry.

[4]  M. Eichelbaum,et al.  Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans , 2004, European Journal of Clinical Pharmacology.

[5]  G. Tucker,et al.  Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. , 1996, The Biochemical journal.

[6]  B. Wang,et al.  Building Fluorescent Sensors by Template Polymerization: The Preparation of a Fluorescent Sensor for l-Tryptophan☆ , 1999 .

[7]  W. Wang,et al.  Building fluorescent sensors by template polymerization: the preparation of a fluorescent sensor for D-fructose. , 1999, Organic letters.

[8]  Nico P. E. Vermeulen,et al.  A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building , 1993, J. Comput. Aided Mol. Des..

[9]  Y. Ge,et al.  Selectivity of response in fluorescent polymers imprinted with N1-benzylidene pyridine-2-carboxamidrazones , 2001 .

[10]  A. Tong,et al.  Molecular imprinting-based fluorescent chemosensor for histamine using zinc(II)–protoporphyrin as a functional monomer , 2002 .

[11]  Eric F. Johnson,et al.  Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution , 2004, Journal of Biological Chemistry.

[12]  W U Primrose,et al.  A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. , 1996, Biochemistry.

[13]  D. Reinhoudt,et al.  9-(Guanidinomethyl)-10-vinylanthracene: a suitable fluorescent monomer for MIPs , 2001 .

[14]  K. Mosbach,et al.  Molecularly imprinted polymers and their use in biomimetic sensors. , 2000, Chemical reviews.

[15]  Barbara Wandelt,et al.  Fluorescent Functional Recognition Sites through Molecular Imprinting. A Polymer-Based Fluorescent Chemosensor for Aqueous cAMP. , 1998 .

[16]  Karthik Venkatakrishnan,et al.  Nortriptyline E‐10‐Hydroxylation in Vitro Is Mediated by Human CYP2D6 (High Affinity) and CYP3A4 (Low Affinity): Implications for Interactions with Enzyme‐Inducing Drugs , 1999, Journal of clinical pharmacology.

[17]  Sergey A. Piletsky,et al.  “Bite‐and‐Switch” Approach to Creatine Recognition by Use of Molecularly Imprinted Polymers , 2000 .

[18]  C David Stout,et al.  Structure of Human Microsomal Cytochrome P450 2C8 , 2004, Journal of Biological Chemistry.

[19]  J. Brockmöller,et al.  Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteers. , 2002, Pharmacogenetics.

[20]  SELECTIVE RECOGNITION OF CYCLIC GMP USING A FLUORESCENCE-BASED MOLECULARLY IMPRINTED POLYMER , 2002 .

[21]  F. Guengerich,et al.  Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. , 1993, Journal of medicinal chemistry.

[22]  Nathalie Lavignac,et al.  4-(3-Aminopropylene)-7-nitrobenzofurazan: a new polymerisable monomer for use in homogeneous molecularly imprinted sorbent fluoroassays , 2004 .

[23]  M. Lam,et al.  A Sol-gel Derived Molecular Imprinted Luminescent PET Sensing Material for 2,4-Dichlorophenoxyacetic Acid , 2001 .

[24]  M. Eichelbaum,et al.  Defective N-oxidation of sparteine in man: A new pharmacogenetic defect , 1979, European Journal of Clinical Pharmacology.

[25]  S D Hall,et al.  Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. , 1997, Biochemical pharmacology.

[26]  J. Matsui,et al.  Moleculary imprinted polymers with metalloporphyrin-based molecular recognition sites coassembled with methacrylic acid. , 2001, Analytical chemistry.

[27]  M J Sternberg,et al.  A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. , 1991, Carcinogenesis.

[28]  G. D. Darling,et al.  Fluorescent molecularly imprinted polymer studied by time-resolved fluorescence spectroscopy , 2002 .

[29]  S. Hall,et al.  Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[30]  Nico P E Vermeulen,et al.  Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. , 2003, Journal of medicinal chemistry.

[31]  D. Avnir,et al.  Phase transfer catalysis in N‐alkylations of the pharmaceutical intermediates 5H‐dibenz[b,f]azepine and 5H‐10,11‐dihydrodibenz[b,f]azepine , 1982 .

[32]  D. Billington,et al.  Molecular recognition by fluorescent imprinted polymers , 2000 .

[33]  Cameron Alexander,et al.  Imprinted polymers: artificial molecular recognition materials with applications in synthesis and catalysis , 2003 .

[34]  D. Flockhart,et al.  Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[35]  D. Sonnichsen,et al.  Clinically Significant Cytochrome P‐450 Drug Interactions—A Comment , 1998, Pharmacotherapy.

[36]  Jose Cosme,et al.  Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.

[37]  L. Ereshefsky,et al.  Antidepressant Drug Interactions and the Cytochrome P450 System , 1995, Clinical pharmacokinetics.

[38]  A. Alex,et al.  Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. , 1999, Journal of medicinal chemistry.

[39]  C. Allender,et al.  Molecularly imprinted polymers--preparation, biomedical applications and technical challenges. , 1999, Progress in medicinal chemistry.